diagnosis and control for multi-agent systems using immune networks
... objects: (1) predator, (2) obstacles, and (3) food. It is assumed that pre-specified quantity of initial energy is given to the immunoid at the beginning of each ...
... objects: (1) predator, (2) obstacles, and (3) food. It is assumed that pre-specified quantity of initial energy is given to the immunoid at the beginning of each ...
IntrauterIne InsemInatIon (IuI)
... IUI is mainly used when timed intercourse or hormonal medications alone have not worked, or if there are ‘mild’ sperm abnormalities, such as poor motility (e.g. the ability of the sperm to move). It is also used in conjunction with donor sperm by same sex female couples or by women who don’t have a ...
... IUI is mainly used when timed intercourse or hormonal medications alone have not worked, or if there are ‘mild’ sperm abnormalities, such as poor motility (e.g. the ability of the sperm to move). It is also used in conjunction with donor sperm by same sex female couples or by women who don’t have a ...
Host Defense Mechanisms – Adaptive or Acquired Immunity
... the body is stimulated to produce its own immune cells and substances, while in other cases (passive immunity) it is not. Some types of acquisition (natural immunity) involve natural mechanisms available to humans and other organisms because of the ways their populations have evolved over time, whil ...
... the body is stimulated to produce its own immune cells and substances, while in other cases (passive immunity) it is not. Some types of acquisition (natural immunity) involve natural mechanisms available to humans and other organisms because of the ways their populations have evolved over time, whil ...
Cancer Vaccines for Hematologic Malignancies
... and more effective combination chemotherapy, improved radiation delivery, and the major impact conferred by bone marrow transplantation (BMT). In spite of these successes, a significant portion of patients with hematologic tumors will ultimately die of their disease. In recent years, therefore, much ...
... and more effective combination chemotherapy, improved radiation delivery, and the major impact conferred by bone marrow transplantation (BMT). In spite of these successes, a significant portion of patients with hematologic tumors will ultimately die of their disease. In recent years, therefore, much ...
ImVacS 2012 Immunotherapeutics and Vaccine
... The giant keyhole limpet Megathura crenulata, is an unlikely organism for commercial mariculture compliant with GMP standards. Discovery by immunologists > 50 yrs ago , that the hemocyanin oxygen-carrier protein constituted also an extremely effective antigen-carrier for inducing immunity, heralded ...
... The giant keyhole limpet Megathura crenulata, is an unlikely organism for commercial mariculture compliant with GMP standards. Discovery by immunologists > 50 yrs ago , that the hemocyanin oxygen-carrier protein constituted also an extremely effective antigen-carrier for inducing immunity, heralded ...
Common Mechanisms
... 1, 1998, or later were somewhat more likely to list MMR (67.0% vs 59.3%) than reports received earlier. Reports received on August 1, 1999, or later were more likely to list hepatitis B (18.1% vs 5.1%), Haemophilus influenzae type B (38.6% vs 28.2%), and diphtheria–tetanus–acellular pertussis (26.5% ...
... 1, 1998, or later were somewhat more likely to list MMR (67.0% vs 59.3%) than reports received earlier. Reports received on August 1, 1999, or later were more likely to list hepatitis B (18.1% vs 5.1%), Haemophilus influenzae type B (38.6% vs 28.2%), and diphtheria–tetanus–acellular pertussis (26.5% ...
PLGA manuscript_final submission
... controlled drug delivery for biopharmaceuticals (Abbas, 2008; Jiang et al., 2005; Kim et al., 2016; Santillan et al., 2011). Biodegradable particles with entrapped vaccine antigens, such as proteins, peptide or DNA, have recently been shown to possess significant potential as vaccine delivery system ...
... controlled drug delivery for biopharmaceuticals (Abbas, 2008; Jiang et al., 2005; Kim et al., 2016; Santillan et al., 2011). Biodegradable particles with entrapped vaccine antigens, such as proteins, peptide or DNA, have recently been shown to possess significant potential as vaccine delivery system ...
Human Papilloma Virus 2017
... administered to persons who are immunocompromised as a result of infection (including HIV infection), disease, or medications. HPV vaccine can be administered to persons with a history of genital warts, abnormal Papanicolaou test, or positive HPV DNA test. ...
... administered to persons who are immunocompromised as a result of infection (including HIV infection), disease, or medications. HPV vaccine can be administered to persons with a history of genital warts, abnormal Papanicolaou test, or positive HPV DNA test. ...
a new frontier in t-cell activation and targeting
... Citrullination occurs as a result of a degradation and ‘recycling’ process called autophagy* that is induced in stressed cells including cancer cells * 2016 Nobel Prize in physiology/medicine awarded to Prof Ohsumi for discovery of autophagy mechanisms PAD = peptidylarginine deiminase ...
... Citrullination occurs as a result of a degradation and ‘recycling’ process called autophagy* that is induced in stressed cells including cancer cells * 2016 Nobel Prize in physiology/medicine awarded to Prof Ohsumi for discovery of autophagy mechanisms PAD = peptidylarginine deiminase ...
Studying HLA antigens in immune incompatible
... of the immune system occurs in allo- and autoimmune pathological pregnancy. During pregnancy mother’s body constantly contacts with cells carrying genetically foreign allogenic antigens. During physiological pregnancy mother’s body shows immune tolerability to the fetus but in some cases fetal antig ...
... of the immune system occurs in allo- and autoimmune pathological pregnancy. During pregnancy mother’s body constantly contacts with cells carrying genetically foreign allogenic antigens. During physiological pregnancy mother’s body shows immune tolerability to the fetus but in some cases fetal antig ...
HuCAL® Antibodies Technical Manual Introduction to Recombinant
... This has been driven in part by advances in recombinant antibody technology. At the forefront of these advances is the Human Combinatorial Antibody Library (HuCAL®), one of the most powerful synthetic antibody libraries ever created. The HuCAL library is a highly sophisticated tool with features tha ...
... This has been driven in part by advances in recombinant antibody technology. At the forefront of these advances is the Human Combinatorial Antibody Library (HuCAL®), one of the most powerful synthetic antibody libraries ever created. The HuCAL library is a highly sophisticated tool with features tha ...
Specification sheet
... PM163-6ml RTU PM163-3ml RTU CM163-0.1ml Conc CM163-0.5ml Conc HAM163-6ml RTU HAM163-3ml RTU ...
... PM163-6ml RTU PM163-3ml RTU CM163-0.1ml Conc CM163-0.5ml Conc HAM163-6ml RTU HAM163-3ml RTU ...
Pertussis (Whooping Cough) Pertussis (Whooping Cough)
... pertussis (dTpa) vaccine? • All children 13 years of age (offered to students in year 8 in the Northern Territory) • Pregnant women – the best time to administer the dTpa vaccine is between 28 and 32 weeks of pregnancy but can be given anytime from 28 weeks of pregnancy up to and immediately after ...
... pertussis (dTpa) vaccine? • All children 13 years of age (offered to students in year 8 in the Northern Territory) • Pregnant women – the best time to administer the dTpa vaccine is between 28 and 32 weeks of pregnancy but can be given anytime from 28 weeks of pregnancy up to and immediately after ...
intrauterine insemination (iui) - Fertility Associates of Memphis
... Prior to Therapeutic Donor Insemination (TDI), you will undergo screening for rubella, HIV, cytomegalovirus antibody IgG and IgM, hepatitis B and C, Chlamydia and gonorrhea as well as blood typing. Your husband will need HIV, cytomegalovirus antibody IgG and IgM, hepatitis B and C and blood type te ...
... Prior to Therapeutic Donor Insemination (TDI), you will undergo screening for rubella, HIV, cytomegalovirus antibody IgG and IgM, hepatitis B and C, Chlamydia and gonorrhea as well as blood typing. Your husband will need HIV, cytomegalovirus antibody IgG and IgM, hepatitis B and C and blood type te ...
Isolated Hepatitis B Core Antibody positive test results
... We have recently received an isolated hepatitis B core antibody result (anti-HBc positive, HBsAg negative and anti-HBs negative) for this patient. These findings may have 4 possible interpretations: 1. False positive Anti-HBc This is the most likely scenario in BC, where HBV prevalence is low. Clien ...
... We have recently received an isolated hepatitis B core antibody result (anti-HBc positive, HBsAg negative and anti-HBs negative) for this patient. These findings may have 4 possible interpretations: 1. False positive Anti-HBc This is the most likely scenario in BC, where HBV prevalence is low. Clien ...
PRESS RELEASE 2011-10-03 The 2011 Nobel Prize in Physiology or Medicine
... We live in a dangerous world. Pathogenic microorganisms (bacteria, virus, fungi, and parasites) threaten us continuously but we are equipped with powerful defense mechanisms (please see figures on page 5). The first line of defense, innate immunity, can destroy invading microorganisms and trigger in ...
... We live in a dangerous world. Pathogenic microorganisms (bacteria, virus, fungi, and parasites) threaten us continuously but we are equipped with powerful defense mechanisms (please see figures on page 5). The first line of defense, innate immunity, can destroy invading microorganisms and trigger in ...
Room for Improvement: Immunizations for Patients With Monoclonal
... immunogenicity in patients with CLL (Table 2). An older study, by Marotta and colleagues, evaluated the response to 2 doses of an inactivated whole-virus vaccine administered 31 days apart.53 This study noted an association between vaccine response (defined as a hemagglutinin inhibition assay [HI] t ...
... immunogenicity in patients with CLL (Table 2). An older study, by Marotta and colleagues, evaluated the response to 2 doses of an inactivated whole-virus vaccine administered 31 days apart.53 This study noted an association between vaccine response (defined as a hemagglutinin inhibition assay [HI] t ...
Chapter 19 Disorders Associated with the Immune System
... the human immunodeficiency virus (HIV), which destroys helper T cells. AIDS is the final stage of a lengthy HIV infection. At this time the loss of an effective immune system leaves the victim susceptible to many opportunistic infections. HIV is a retrovirus and requires the enzyme reverse transcrip ...
... the human immunodeficiency virus (HIV), which destroys helper T cells. AIDS is the final stage of a lengthy HIV infection. At this time the loss of an effective immune system leaves the victim susceptible to many opportunistic infections. HIV is a retrovirus and requires the enzyme reverse transcrip ...
Vaccination to prevent cervical cancer – offered to all girls in grade 7
... Any vaccine can in rare cases cause an allergic reaction such as a rash or itching shortly after the vaccine was given. In rare cases, vaccines can cause more serious allergic reactions. Healthcare personnel who give vaccines are prepared to deal with this type of reaction. ...
... Any vaccine can in rare cases cause an allergic reaction such as a rash or itching shortly after the vaccine was given. In rare cases, vaccines can cause more serious allergic reactions. Healthcare personnel who give vaccines are prepared to deal with this type of reaction. ...
Antigen targeting to dendritic cells elicits long
... and bone marrow was measured by ELISPOT. We found NP-specific antibody-producing cells in the spleen and bone marrow (Fig. 2 B) of mice immunized with anti–DEC-OVA plus maturation stimulus and with alum plus OVA. Collectively, these results lead us to conclude that immunization by antigen targeting ...
... and bone marrow was measured by ELISPOT. We found NP-specific antibody-producing cells in the spleen and bone marrow (Fig. 2 B) of mice immunized with anti–DEC-OVA plus maturation stimulus and with alum plus OVA. Collectively, these results lead us to conclude that immunization by antigen targeting ...
- Critical Care Clinics
... A general appreciation for disease resistance on re-exposure to the same disease process was also well appreciated even in ancient times. The Greek historian Thucydides recorded that smallpox survivors did not get reinfected during subsequent epidemics of smallpox. Some form of acquired immunity dev ...
... A general appreciation for disease resistance on re-exposure to the same disease process was also well appreciated even in ancient times. The Greek historian Thucydides recorded that smallpox survivors did not get reinfected during subsequent epidemics of smallpox. Some form of acquired immunity dev ...
Act-HIB - VaccineShoppeCanada
... Older children and adults with asplenia or hyposplenism (including sickle cell anemia, thalassemia major, essential thrombocytopenia, celiac disease and inflammatory bowel disease); those with defects in antibody production (e.g., agammaglobulinemia, isotype and IgG subclass deficiencies and hyper-I ...
... Older children and adults with asplenia or hyposplenism (including sickle cell anemia, thalassemia major, essential thrombocytopenia, celiac disease and inflammatory bowel disease); those with defects in antibody production (e.g., agammaglobulinemia, isotype and IgG subclass deficiencies and hyper-I ...
